Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds

被引:44
|
作者
Hultman, Ia [1 ]
Vedin, Charlotta [1 ]
Abrahamsson, Anna [2 ]
Winiwarter, Susanne [1 ]
Darnell, Malin [1 ]
机构
[1] AstraZeneca R&D Gothenburg, Drug Safety & Metab, S-43183 Molndal, Sweden
[2] AstraZeneca R&D Gothenburg, RIA iMed DMPK, S-43183 Molndal, Sweden
关键词
H mu REL coculture; slowly metabolized drugs; low CLint; clearance prediction; P450; activity; metabolite formation; CRYOPRESERVED HUMAN HEPATOCYTES; CIRCULATING DRUG METABOLITES; BINDING; PHARMACOKINETICS; CHALLENGE; STABILITY; DISCOVERY; HEPARG; CELLS;
D O I
10.1021/acs.molpharmaceut.6b00396
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Design of slowly metabolized compounds is an important goal in many drug discovery projects. Standard hepatocyte suspension intrinsic clearance (CLint) methods can only provide reliable CLint values above 2.5 mu L/min/million cells. A method that permits extended incubation time with maintained performance and metabolic activity of the in vitro system is warranted to allow in vivo clearance predictions and metabolite identification of slowly metabolized drugs. The aim of this study was to evaluate the static H mu REL coculture of human hepatocytes with stromal cells to be set up in-house as a standard method for in vivo clearance prediction and metabolite identification of slowly metabolized drugs. Fourteen low CLint compounds were incubated for 3 days, and seven intermediate to high CLint compounds and a cocktail of cytochrome P450 (P450) marker substrates were incubated for 3 h. In vivo clearance was predicted for 20 compounds applying the regression line approach, and H mu REL coculture predicted the human intrinsic clearance for 45% of the drugs within 2-fold and 70% of the drugs within 3-fold of the clinical values. CLint values as low as 0.3 mu L/min/million hepatocytes were robustly produced, giving 8-fold improved sensitivity of robust low CLint determination, over the cutoff in hepatocyte suspension CLint methods. The CLint values of intermediate to high CLint compounds were at similar levels both in H mu REL coculture and in freshly thawed hepatocytes. In the H mu REL coculture formation rates for five P450-isoform marker reactions, paracetamol (CYP1A2), 1-OH-bupropion (CYP2B6), 4-OH-diclofenac (CYP2C9), and 1-OH-midazolam (3A4) were within the range of literature values for freshly thawed hepatocytes, whereas 1-OH-bufuralol (CYP2D6) formation rate was lower. Further, both phase I and phase II metabolites were detected and an increased number of metabolites were observed in the H mu REL coculture compared to hepatocyte suspension. In conclusion, H mu REL coculture can be applied to accurately estimate intrinsic clearance of slowly metabolized drugs and is now utilized as a standard method for in vivo clearance prediction of such compounds in-house.
引用
收藏
页码:2796 / 2807
页数:12
相关论文
共 13 条
  • [1] PLATED HEPATOCYTE RELAY ASSAY (PHRA) FOR THE ESTIMATION OF INTRINSIC HEPATIC CLEARANCE AND METABOLITE PROFILE OF SLOWLY METABOLIZED COMPOUNDS
    Li, Albert P.
    Peng, Chi-Chi
    Doshi, Utkarsh
    Prakash, Chandra
    DRUG METABOLISM REVIEWS, 2015, 47 : 53 - 54
  • [2] Comparison of Human Long-Term Liver Models for Clearance Prediction of Slowly Metabolized Compounds
    Preiss, Lena C.
    Georgi, Katrin
    Lauschke, Volker M.
    Petersson, Carl
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (06) : 539 - 547
  • [3] EVALUATION OF A COST-EFFECTIVE IN VITRO HUMAN MODEL FOR PREDICTING INTRINSIC HEPATOCYTE CLEARANCE OF SLOWLY METABOLIZED COMPOUNDS
    Delvaux, Nathan
    Lavarias, Mitchell
    Sampson, Kathleen
    Albaugh, Daniel
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [4] Use of intrinsic clearance for prediction of human hepatic clearance
    Chao, Piyun
    Uss, Annette S.
    Cheng, K. C.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (02) : 189 - 198
  • [5] Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds
    Preiss, Lena C.
    Lauschke, Volker M.
    Georgi, Katrin
    Petersson, Carl
    AAPS JOURNAL, 2022, 24 (02):
  • [6] Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds
    Lena C. Preiss
    Volker M. Lauschke
    Katrin Georgi
    Carl Petersson
    The AAPS Journal, 24
  • [7] Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG
    Bonn, Britta
    Svanberg, Petter
    Janefeldt, Annika
    Hultman, Ia
    Grime, Ken
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (04) : 527 - 533
  • [8] Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds
    Sohlenius-Sternbeck, Anna-Karin
    Afzelius, Lovisa
    Prusis, Peteris
    Neelissen, Jan
    Hoogstraate, Janet
    Johansson, Jenny
    Floby, Eva
    Bengtsson, Annelie
    Gissberg, Olle
    Sternbeck, John
    Petersson, Carl
    DRUG METABOLISM REVIEWS, 2010, 42 : 56 - 56
  • [9] Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds
    Sohlenius-Sternbeck, A. -K.
    Afzelius, L.
    Prusis, P.
    Neelissen, J.
    Hoogstraate, J.
    Johansson, J.
    Floby, E.
    Bengtsson, A.
    Gissberg, O.
    Sternbeck, J.
    Petersson, C.
    XENOBIOTICA, 2010, 40 (09) : 637 - 649
  • [10] Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set
    Yamagata, Tetsuo
    Zanelli, Ugo
    Gallemann, Dieter
    Perrin, Dominique
    Dolgos, Hugues
    Petersson, Carl
    XENOBIOTICA, 2017, 47 (09) : 741 - 751